Inadequacy of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28224933)

Published in Am Heart J on November 03, 2016

Authors

Glen P Martin1, Matthew Sperrin1, Peter F Ludman2, Mark A de Belder3, Chris P Gale4, William D Toff5, Neil E Moat6, Uday Trivedi7, Iain Buchan1, Mamas A Mamas8

Author Affiliations

1: Health e-Research Centre, University of Manchester, Manchester, United Kingdom.
2: Queen Elizabeth Hospital, Birmingham, United Kingdom.
3: James Cook University Hospital, Middlesbrough, United Kingdom.
4: MRC Bioinformatics Unit, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.
5: Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Wing, Glenfield General Hospital, Leicester, United Kingdom; NIHR Leicester Cardiovascular Biomedical Research Unit, Leicester, United Kingdom.
6: Royal Brompton and Harefield National Health Service (NHS) Foundation Trust, London, United Kingdom.
7: Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton,United Kingdom.
8: Health e-Research Centre, University of Manchester, Manchester, United Kingdom; Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, UK, Royal Stoke Hospital, University Hospitals North Midlands, Stoke-on-Trent, United Kingdom. Electronic address: mamasmamas1@yahoo.co.uk.

Articles cited by this

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ (2009) 19.23

pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics (2011) 16.75

Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70

Guidelines on the management of valvular heart disease (version 2012). Eur Heart J (2012) 10.70

Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol (2001) 10.16

EuroSCORE II. Eur J Cardiothorac Surg (2012) 9.52

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med (2016) 6.95

Prognosis and prognostic research: validating a prognostic model. BMJ (2009) 6.54

The logistic EuroSCORE. Eur Heart J (2003) 4.94

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45

Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med (2004) 2.95

Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score. Heart (2014) 2.94

Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J (2005) 2.83

Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J (2010) 2.63

Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J (2012) 2.22

Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Catheter Cardiovasc Interv (2011) 1.98

Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system--a Bern-Rotterdam Study. Am Heart J (2010) 1.87

Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol (2013) 1.62

Comparison between Society of Thoracic Surgeons score and logistic EuroSCORE for predicting mortality in patients referred for transcatheter aortic valve implantation. Cardiovasc Revasc Med (2011) 1.57

Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. Circulation (2015) 1.42

Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. Circulation (2014) 1.34

Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J (2012) 1.33

Transapical aortic valve implantation: analysis of risk factors and learning experience in 299 patients. Circulation (2011) 1.28

A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol (2014) 1.08

Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol (2014) 1.04

German Aortic Valve Score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg (2013) 0.98

External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges. BMJ (2016) 0.96

Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement. JAMA Cardiol (2016) 0.87

The UK transcatheter aortic valve implantation registry; one of the suite of registries hosted by the National Institute for Cardiovascular Outcomes Research (NICOR). Heart (2012) 0.87

TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. Eur Heart J (2016) 0.85

Impact of frailty on short- and long-term morbidity and mortality after transcatheter aortic valve implantation: risk assessment by Katz Index of activities of daily living. EuroIntervention (2014) 0.81

Mortality prediction following transcatheter aortic valve replacement: A quantitative comparison of risk scores derived from populations treated with either surgical or percutaneous aortic valve replacement. The Israeli TAVR Registry Risk Model Accuracy Assessment (IRRMA) study. Int J Cardiol (2016) 0.77

Prevalence and Impact of Co-morbidity Burden as Defined by the Charlson Co-morbidity Index on 30-Day and 1- and 5-Year Outcomes After Coronary Stent Implantation (from the Nobori-2 Study). Am J Cardiol (2015) 0.77